GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » QLY Biotech Group Corp (OTCPK:LQLY) » Definitions » Cash, Cash Equivalents, Marketable Securities

QLY Biotech Group (QLY Biotech Group) Cash, Cash Equivalents, Marketable Securities : $0.00 Mil (As of Feb. 2023)


View and export this data going back to 2021. Start your Free Trial

What is QLY Biotech Group Cash, Cash Equivalents, Marketable Securities?

QLY Biotech Group's annual cash, cash equivalents, marketable securities declined from Aug. 2020 ($0.03 Mil) to Aug. 2021 ($0.01 Mil) and declined from Aug. 2021 ($0.01 Mil) to Aug. 2022 ($0.00 Mil).


QLY Biotech Group Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for QLY Biotech Group's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QLY Biotech Group Cash, Cash Equivalents, Marketable Securities Chart

QLY Biotech Group Annual Data
Trend Aug19 Aug20 Aug21 Aug22
Cash, Cash Equivalents, Marketable Securities
0.01 0.03 0.01 -

QLY Biotech Group Quarterly Data
Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

QLY Biotech Group Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


QLY Biotech Group  (OTCPK:LQLY) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


QLY Biotech Group Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of QLY Biotech Group's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


QLY Biotech Group (QLY Biotech Group) Business Description

Industry
Traded in Other Exchanges
N/A
Address
5348 Vegas Drive, Las Vegas, NV, USA, 89108
Website
QLY Biotech Group Corp is a United States based company engaged in the tourism business.

QLY Biotech Group (QLY Biotech Group) Headlines

No Headlines